VisionWave begins staged equity deal with SaverOne

VisionWave Holdings, Inc. entered the first stage of a staged equity exchange and strategic collaboration with Israeli company SaverOne 2014 Ltd. on March 5, 2026.

Rhea-AI Filing Summary

VisionWave Holdings, Inc. entered the first stage of a staged equity exchange and strategic collaboration with Israeli company SaverOne 2014 Ltd. on March 5, 2026. This structure is intended to result in VisionWave ultimately beneficially owning about 51% of SaverOne’s ordinary shares on a fully diluted basis, excluding certain dilutive effects, while SaverOne will receive VisionWave common stock valued at $7 million subject to a value protection mechanism.

At the Stage 1 closing, VisionWave issued 365,610 restricted common shares to SaverOne, valued at approximately $2.7 million using a VWAV average price of $7.5031 per share, in exchange for 148,584 restricted SaverOne ADSs representing 19.99% of SaverOne’s issued and outstanding share capital as of the exchange agreement’s effective date. VisionWave will also issue shares to management under a $3 million pool based on a 39.1877% allocation and has granted SaverOne a non‑exclusive license to certain RF‑related intellectual property to support RF‑focused defense and military technology initiatives. The VisionWave shares were issued in a private placement relying on the Section 4(a)(2) exemption from registration under the Securities Act.

Insights

M&A and Capital Markets Analyst

VisionWave begins staged stock-for-stock deal to take control of SaverOne.

VisionWave is using a staged equity exchange with SaverOne 2014 Ltd. that combines share swaps and an intellectual property license. Stage 1 involves issuing 365,610 restricted VisionWave shares, valued at about $2.7 million, for 148,584 restricted SaverOne ADSs.

The exchange agreement contemplates VisionWave ultimately beneficially owning approximately 51% of SaverOne’s ordinary shares on a fully diluted basis, while SaverOne receives VisionWave stock valued at $7 million subject to a value protection mechanism. This structure ties the parties’ interests together and adds an RF‑focused defense and military technology collaboration.

The Stage 1 VisionWave shares were issued as an unregistered private placement under Section 4(a)(2) of the Securities Act, so future investor impact will depend on how subsequent stages progress and on SaverOne’s performance once VisionWave’s stake increases.

8-K Event Classification

2 items: 3.02, 9.01

2 items

Item 3.02 Unregistered Sales of Equity Securities Securities

The company sold equity securities in a private placement or other unregistered transaction.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did VisionWave Holdings (VWAV) announce with SaverOne 2014 Ltd.?

VisionWave entered a staged equity exchange and strategic collaboration with SaverOne. Ultimately, VisionWave aims to beneficially own about 51% of SaverOne’s ordinary shares, while SaverOne will receive VisionWave common stock valued at $7 million, subject to a value protection mechanism.

How many VisionWave shares were issued in the Stage 1 closing with SaverOne?

In the Stage 1 closing, VisionWave issued 365,610 restricted common shares to SaverOne. These shares were valued at approximately $2.7 million, based on a VWAV average price of $7.5031 per share as defined in the exchange agreement between the companies.

What stake in SaverOne did VisionWave receive in the Stage 1 exchange?

VisionWave received 148,584 restricted SaverOne ADSs in Stage 1, representing 6,418,828,800 restricted ordinary shares. This equals 19.99% of SaverOne’s issued and outstanding share capital as of the exchange agreement’s effective date, calculated on a fully diluted basis excluding certain future issuances.

How will ownership look after all stages of the VisionWave–SaverOne exchange?

Upon completion of all stages, VisionWave expects to beneficially own approximately 51% of SaverOne’s issued and outstanding ordinary shares on a fully diluted basis. SaverOne will hold VisionWave common stock with an aggregate value of $7 million, protected by a value protection mechanism.

Was the issuance of VisionWave shares to SaverOne registered with the SEC?

The VisionWave shares issued to SaverOne in Stage 1 were not registered with the SEC. They were issued as restricted shares in a private placement relying on the Section 4(a)(2) exemption under the Securities Act, limiting resale unless a registration or exemption applies.

What intellectual property rights did VisionWave grant to SaverOne in this deal?

VisionWave granted SaverOne a non-exclusive license to certain RF-related intellectual property. This license is intended to support development of RF-focused defense and military technology initiatives, aligning the companies’ technological efforts alongside the staged equity exchange structure between VisionWave and SaverOne.

How are VisionWave management incentives structured in the Stage 1 exchange?

VisionWave will issue additional shares to management under Schedule 1.7 of the January 26, 2026 agreement. This includes the applicable portion of a $3 million pool, with 39.1877% allocated at the Stage 1 closing, aligning management incentives with the SaverOne collaboration.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/09/2026 - 05:04 PM Learn about SEC filing dates

false 0002038439 0002038439 2026-03-05 2026-03-05 0002038439 VWAV:CommonStockParValue0.01PerShareMember 2026-03-05 2026-03-05 0002038439 VWAV:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member 2026-03-05 2026-03-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 5, 2026

VisionWave Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware		001-72741		99-5002777
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

300 Delaware Ave., Suite 210 # 301 Wilmington, DE.		19801
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (302) 305-4790

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, par value $0.01 per share		VWAV		The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50		VWAVW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.02 Unregistered Sales of Equity Securities.

On March 5, 2026, VisionWave Holdings, Inc. (the “Company”) completed the initial closing (the “Stage 1 Closing”) pursuant to the Exchange Agreement, dated as of January 26, 2026 (the “Exchange Agreement”), by and between the Company and SaverOne 2014 Ltd. (“SaverOne”), an Israeli company whose American Depositary Shares (“ADS”)are listed on the Nasdaq Stock Market.

As previously disclosed in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on January 26, 2026, the Exchange Agreement provides for a staged equity exchange and strategic collaboration, pursuant to which, upon completion of all stages, the Company will beneficially own approximately 51% of SaverOne's issued and outstanding ordinary shares (on a fully diluted basis, excluding certain dilutive effects), and SaverOne will own shares of the Company's common stock having an aggregate value of $7 million (subject to a value protection mechanism). The transactions also include the grant by the Company to SaverOne of a non-exclusive license to certain of the Company's RF-related intellectual property to support the development of the Company's RF-focused defense and military technology initiatives.

At the Stage 1 Closing, the Company issued 365,610 shares of its restricted shares of common stock (the "Stage 1 VisionWave Shares") to SaverOne, having an aggregate value of approximately $2.7 million, calculated based on the VWAV Average Price (as defined in the Exchange Agreement) of $7.5031 per share. In exchange, SaverOne issued to the Company148,584 restricted ADSs (representing 6,418,828,800 restricted ordinary shares) representing 19.99% of SaverOne's issued and outstanding share capital as of the effective date of the Exchange Agreement (calculated on a fully diluted basis, excluding any dilutive effects from future issuances unrelated to the Exchange Agreement).

In addition, the Company will issue the corresponding shares issuable to management at the Stage 1 Closing pursuant to Schedule 1.7 of the January 26, 2026 Agreement, including the applicable portion of the $3 million pool (39.1877%).

The Stage 1 VisionWave Shares were issued in a private placement in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). The Company did not engage in general solicitation or advertising with regard to the issuance and sale of the Stage 1 VisionWave Shares and has not offered securities to the public in connection with such issuance and sale. The Stage 1 VisionWave Shares have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

The foregoing description of the Stage 1 Closing and the Exchange Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Exchange Agreement, which was filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 26, 2026, and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
10.1		Exchange Agreement, dated as of January 26, 2026, by and between VisionWave Holdings, Inc. and SaverOne 2014 Ltd. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 26, 2026).
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

VISIONWAVE HOLDINGS, INC.
By:	/s/ Douglas Davis
Name:	Douglas Davis
Title:	Executive Chairman and Interim Chief Executive Officer
Date:	March 9, 2026

Filing Exhibits & Attachments

5 documents

Agreements & Contracts

• EX-10.1 EXHIBIT 10.1 258.4 KB

Other Documents

• EX-101 XBRL SCHEMA FILE 3.8 KB
• EX-101 XBRL DEFINITION FILE 26.1 KB
• EX-101 XBRL LABEL FILE 36.1 KB
• EX-101 XBRL PRESENTATION FILE 24.8 KB